Cargando…
Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775073/ https://www.ncbi.nlm.nih.gov/pubmed/31578317 http://dx.doi.org/10.1038/s41408-019-0242-4 |
| _version_ | 1783456157843587072 |
|---|---|
| author | Das, Andrew B. Kakadia, Purvi M. Wojcik, Damian Pemberton, Lucy Browett, Peter J. Bohlander, Stefan K. Vissers, Margreet C. M. |
| author_facet | Das, Andrew B. Kakadia, Purvi M. Wojcik, Damian Pemberton, Lucy Browett, Peter J. Bohlander, Stefan K. Vissers, Margreet C. M. |
| author_sort | Das, Andrew B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6775073 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67750732019-10-10 Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1 Das, Andrew B. Kakadia, Purvi M. Wojcik, Damian Pemberton, Lucy Browett, Peter J. Bohlander, Stefan K. Vissers, Margreet C. M. Blood Cancer J Letter Nature Publishing Group UK 2019-10-02 /pmc/articles/PMC6775073/ /pubmed/31578317 http://dx.doi.org/10.1038/s41408-019-0242-4 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Das, Andrew B. Kakadia, Purvi M. Wojcik, Damian Pemberton, Lucy Browett, Peter J. Bohlander, Stefan K. Vissers, Margreet C. M. Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1 |
| title | Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1 |
| title_full | Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1 |
| title_fullStr | Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1 |
| title_full_unstemmed | Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1 |
| title_short | Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1 |
| title_sort | clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in tet2 and wt1 |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775073/ https://www.ncbi.nlm.nih.gov/pubmed/31578317 http://dx.doi.org/10.1038/s41408-019-0242-4 |
| work_keys_str_mv | AT dasandrewb clinicalremissionfollowingascorbatetreatmentinacaseofacutemyeloidleukemiawithmutationsintet2andwt1 AT kakadiapurvim clinicalremissionfollowingascorbatetreatmentinacaseofacutemyeloidleukemiawithmutationsintet2andwt1 AT wojcikdamian clinicalremissionfollowingascorbatetreatmentinacaseofacutemyeloidleukemiawithmutationsintet2andwt1 AT pembertonlucy clinicalremissionfollowingascorbatetreatmentinacaseofacutemyeloidleukemiawithmutationsintet2andwt1 AT browettpeterj clinicalremissionfollowingascorbatetreatmentinacaseofacutemyeloidleukemiawithmutationsintet2andwt1 AT bohlanderstefank clinicalremissionfollowingascorbatetreatmentinacaseofacutemyeloidleukemiawithmutationsintet2andwt1 AT vissersmargreetcm clinicalremissionfollowingascorbatetreatmentinacaseofacutemyeloidleukemiawithmutationsintet2andwt1 |